TUCSON, Ariz., June 28 /PRNewswire/ -- Bioptics, Inc. (“Bioptics”) is pleased to announce that it has been awarded a contract by the National Breast Screening Programme (Ireland) along with its local Distributor DAAX Ltd. After a public procurement process, Bioptics and DAAX Ltd. have been selected exclusively to provide Digital Specimen Radiography equipment to BreastCheck clinics throughout Ireland.
Bioptics’ piXarray line of FDA cleared Digital Specimen Radiography products are marketed worldwide and provide state of the art digital specimen imaging of both surgical and core biopsies. Bioptics’ system dramatically improves efficiency by providing full PACS networking, allowing surgeons, radiologists, and pathologists the opportunity to digitally analyze suspected breast tissue on a real-time basis while the patient is on the operating table.
“We are extremely pleased to have been awarded this contract by BreastCheck Ireland and look forward to providing our products and services throughout Ireland. BreastCheck Ireland’s initiative is one of the most impressive in the World and we are excited to be a part of their pioneering efforts”, said Emre Toker, Founder of Bioptics.
For additional information regarding Bioptics or the topic of this release, please contact Mark Brenner at (520) 514-2298 or mbrenner@bioptics-inc.com or see our website at http://www.bioptics-inc.com.
ABOUT Bioptics, Inc. -- Founded in 2001 by Emre Toker in Tucson, Arizona; Bioptics, Inc. has developed FDA cleared Digital Specimen Radiography products (PiXarray) and marketed them throughout the United States, Europe, Asia and Australasia. In addition, Bioptics is pioneering efforts in the Small Field Digital Mammography (SFDM) and Full Field Digital Mammography (FFDM) segments with its development of SFDM and FFDM sensors for upgrading analog mammography systems. Utilizing its unique CMOS technology, Bioptics’ goal is to provide the highest performance and best value solutions to its customers globally.
Bioptics, Inc.
CONTACT: Mark Brenner of Bioptics, Inc., +1-520-514-2298,mbrenner@bioptics-inc.com
Web site: http://www.bioptics-inc.com/
